Logo image of ATRS

ANTARES PHARMA INC (ATRS) Stock Analyst Ratings

NASDAQ:ATRS - Nasdaq - US0366421065 - Common Stock

5.59  0 (0%)

After market: 5.59 0 (0%)

Buy % Consensus

73

ChartMill assigns a Buy % Consensus number of 73% to ATRS. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 6.07. This target is 8.57% above the current price.
ATRS was analyzed by 12 analysts. The buy percentage consensus is at 73. So analysts seem to be have mildly positive about ATRS.
In the previous month the buy percentage consensus was at a similar level.
ATRS was analyzed by 12 analysts, which is quite many. So the average rating should be quite meaningful.

Related screens

ATRS Historical Analyst RatingsATRS Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -66 -60 -54 -48 -42 -36 -30 -24 -18 -12 -6 0 2 4 6 8 10

Price Target & Forecast

Price Low Median Mean High 5.595.665.716.077.35 - 1.18% 2.18% 8.57% 31.48%

Related screens

ATRS Current Analyst RatingATRS Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 1 2 3 4 5
Up and Down Grades
Date Firm Action Rating
2022-04-14 Ladenburg Thalmann Downgrade Buy -> Neutral
2022-04-14 Raymond James Downgrade Strong Buy -> Market Perform
2022-04-14 Truist Securities Downgrade Buy -> Hold
2022-04-14 Piper Sandler Downgrade Overweight -> Neutral
2022-04-14 HC Wainwright & Co. Downgrade Buy -> Neutral
2021-11-05 HC Wainwright & Co. Maintains Buy
2021-07-16 Truist Securities Initiate Buy
2021-05-10 HC Wainwright & Co. Maintains Buy